Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis.

Hong, Namki; Shin, Sungjae; Lee, Seunghyun; Rhee, Yumie

Hong, Namki; Shin, Sungjae; Lee, Seunghyun; Rhee, Yumie.

Afiliación

Hong N; Division of Endocrinology, Department of Internal Medicine, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
Shin S; Division of Endocrinology, Department of Internal Medicine, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
Lee S; Division of Endocrinology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, 10444, Korea.
Rhee Y; Division of Endocrinology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, 26426, Republic of Korea.

Osteoporos Int ; 34(12): 2059-2067, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37596432

Asunto(s)

Fracturas Óseas; Osteoporosis Posmenopáusica; Humanos; Femenino; Persona de Mediana Edad; Osteoporosis Posmenopáusica/tratamiento farmacológico; Osteoporosis Posmenopáusica/inducido químicamente; Denosumab/farmacología; Denosumab/uso terapéutico; Hueso Esponjoso; Moduladores Selectivos de los Receptores de Estrógeno; Fracturas Óseas/inducido químicamente; Vértebras Lumbares; Difosfonatos

Palabras clave

Bone mineral density; Denosumab; Osteoporosis; Postmenopause; Romosozumab; Trabecular bone score

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Osteoporosis Posmenopáusica / Fracturas Óseas Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Osteoporos Int Asunto de la revista: METABOLISMO / ORTOPEDIA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google